World Liver Day 2024 – 19 April
World Liver Day, 19 April 2024 Join us in this important, international campaign
GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)
New European project aims to improve tools and advice to prevent chronic liver illnesses. Utrecht, The Netherlands, 05-02-2024: GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in…
EASL Statement on Resmetirom FDA approval
After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of life and long-term prognosis have been greatly affected…
LIVERAIM: European researchers will conduct the largest trial ever in liver disease
Liver diseases account for 300,000 deaths in Europe each year. With support from the Innovative Health Initiative, a collaboration of researchers, biotechnology companies and the pharmaceutical industry aim to improve the lives and health of people with hidden liver disease…
Launching the second EASL-Lancet Commission on liver health in Europe: prevention, case-finding and early diagnosis to reduce liver-related mortality
Triggered by the rising burden of liver disease, the Lancet and the European Association for the Study of the Liver (EASL) jointly arranged a Commission to explore the landscape of liver health in Europe. The culmination of this work was…
Policy Webinar: Steatotic Liver Disease (SLD) – The missing piece in the NCD puzzle
The European Association for the Study of the Liver (EASL), as part of the Healthy Livers, Healthy Lives Coalition held a policy webinar on 31 January 2024. Moderated by Nicola Bedlington and featuring esteemed speakers from around the world, this…
DECISION: Revolutionising liver disease treatment for improved patient outcomes
The DECISION project, an EU-funded research initiative, is making significant strides in understanding the complex dynamics of acute decompensation of cirrhosis and its progression to acute-on-chronic liver failure (ACLF). In a recent interview, Prof. Pierre-Emmanuel Rautou, DECISION Project Coordinator, provided…
The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer
Endowed with €12 million, the project is coordinated by Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncology, a professor of Medicine at the University of Barcelona (UB) an ICREA professor. The European Union’s THRIVE…
Tribute to Sir Roy Calne (1930-2024)
It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed away at the age of 93. His remarkable…
Calling for EASL Nurses & AHPs Rising Star candidates
The EASL Nurses & AHPs Task Force is delighted to announce this call. We are looking for the next “Rising Star” in our community of liver nurses and Allied Health Professionals (AHPs). Click to see a non-exhaustive list of professions that can…